相关实验视频

Updated: Jan 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

低容量与高容量Impella为CS后AMI:一个系统的审查和数据分析池的数据分析

Dan Haberman¹, Beni Verma¹, Waiel Abusnina¹

¹Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, USA.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

|January 8, 2026

概括

高容量的Impella设备显示,与低容量的设备相比,急性心肌梗塞与心脏性休克 (AMI-CS) 患者的生存率改善,并发症减少. 早期考虑高容量的Impella可能会改善治疗结果.

科学领域:

心脏病学心脏病学
医疗器械医疗器械
临床研究临床研究

背景情况:

带有心脏性休克的急性心肌梗塞 (AMI-CS) 的死亡率很高.
伊佩拉装置提供血液动力学支持,具有最小的侵入性.

研究的目的:

在AMI-CS患者中,比较低容量与高容量的Impella设备的有效性和安全性.
为了确定治疗AMI-CS的最佳Impella配置.

主要方法:

20项涉及3896名AMI-CS患者的研究的系统审查和聚合分析.
高容量 (Impella 5.0/5.5) 与低容量 (Impella 2.5/CP) 设备的比较.
主要结局:住院或30天死亡率. 二次结果:支持死亡率,缺血/出血并发症,需要RRT的AKI,血液溶解.

主要成果:

高容量的Impella与较低的住院/30天死亡率 (41.4%与45.4%) 和支持死亡率 (17.9%与46.1%) 相关.
较少的重大出血事件 (1.4%对6.0%) 和缺血并发症 (3.9%对5.9%) 观察到高容量的Impella.
高容量的Impella (52.1%与23.1%) 需要更高的输血量;中风或需要RRT的AKI没有显著差异.

结论:

高容量的Impella可以在AMI-CS患者中提供优越的生存益处和降低并发症率.
结果表明,高容量Impella的缺血和重大出血事件的发生率较低.
支持在治疗算法中早期考虑高容量的Impella.

更多相关视频

The Intra-Aortic Balloon Pump

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

相关概念视频

Imbalances in Cardiac Output

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...